Global Patchwork Of Bribery Laws Complicates GSK Defense
The involvement of U.S., U.K. and Chinese regulators in the GlaxoSmithKline PLC bribery investigation may create headaches for the pharmaceutical giant as it fights claims under three separate legal regimes, underscoring...To view the full article, register now.
Already a subscriber? Click here to view full article